Adaptive trial designs could accelerate HIV vaccine development
In the past 12 years, four large-scale efficacy trials of HIV vaccines have been conducted in various populations. Results from the most recent trialthe RV144 trial in Thailand, which found a 31 percent reduction ...
Apr 20, 2011
0
0